GM1 gangliosidoses (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "GM1 gangliosidoses" in English language version.

refsWebsite
Global rank English rank
4th place
4th place
2nd place
2nd place
11th place
8th place
9,308th place
8,899th place

doi.org

  • Caciotti A, Garman SC, Rivera-Colón Y, Procopio E, Catarzi S, Ferri L, et al. (July 2011). "GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812 (7): 782–790. doi:10.1016/j.bbadis.2011.03.018. PMC 3210552. PMID 21497194.
  • Jarnes Utz JR, Kim S, King K, Ziegler R, Schema L, Redtree ES, Whitley CB (June 2017). "Infantile gangliosidoses: Mapping a timeline of clinical changes". Molecular Genetics and Metabolism. 121 (2): 170–179. doi:10.1016/j.ymgme.2017.04.011. PMC 5727905. PMID 28476546.
  • Regier DS, Kwon HJ, Johnston J, Golas G, Yang S, Wiggs E, et al. (March 2016). "MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis". American Journal of Medical Genetics. Part A. 170 (3): 634–644. doi:10.1002/ajmg.a.37468. PMID 26646981. S2CID 19466710.
  • Brunetti-Pierri N, Scaglia F (August 2008). "GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects". Molecular Genetics and Metabolism. 94 (4): 391–396. doi:10.1016/j.ymgme.2008.04.012. PMID 18524657.
  • Rha AK, Maguire AS, Martin DR (2021-04-09). "GM1 Gangliosidosis: Mechanisms and Management". The Application of Clinical Genetics. 14: 209–233. doi:10.2147/TACG.S206076. PMC 8044076. PMID 33859490.
  • Nicoli ER, Annunziata I, d'Azzo A, Platt FM, Tifft CJ, Stepien KM (2021-09-03). "GM1 Gangliosidosis-A Mini-Review". Frontiers in Genetics. 12: 734878. doi:10.3389/fgene.2021.734878. PMC 8446533. PMID 34539759.
  • Bley AE, Giannikopoulos OA, Hayden D, Kubilus K, Tifft CJ, Eichler FS (November 2011). "Natural history of infantile G(M2) gangliosidosis". Pediatrics. 128 (5): e1233–e1241. doi:10.1542/peds.2011-0078. PMC 3208966. PMID 22025593.

genome.gov

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Caciotti A, Garman SC, Rivera-Colón Y, Procopio E, Catarzi S, Ferri L, et al. (July 2011). "GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812 (7): 782–790. doi:10.1016/j.bbadis.2011.03.018. PMC 3210552. PMID 21497194.
  • Jarnes Utz JR, Kim S, King K, Ziegler R, Schema L, Redtree ES, Whitley CB (June 2017). "Infantile gangliosidoses: Mapping a timeline of clinical changes". Molecular Genetics and Metabolism. 121 (2): 170–179. doi:10.1016/j.ymgme.2017.04.011. PMC 5727905. PMID 28476546.
  • Regier DS, Kwon HJ, Johnston J, Golas G, Yang S, Wiggs E, et al. (March 2016). "MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis". American Journal of Medical Genetics. Part A. 170 (3): 634–644. doi:10.1002/ajmg.a.37468. PMID 26646981. S2CID 19466710.
  • Brunetti-Pierri N, Scaglia F (August 2008). "GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects". Molecular Genetics and Metabolism. 94 (4): 391–396. doi:10.1016/j.ymgme.2008.04.012. PMID 18524657.
  • Rha AK, Maguire AS, Martin DR (2021-04-09). "GM1 Gangliosidosis: Mechanisms and Management". The Application of Clinical Genetics. 14: 209–233. doi:10.2147/TACG.S206076. PMC 8044076. PMID 33859490.
  • Nicoli ER, Annunziata I, d'Azzo A, Platt FM, Tifft CJ, Stepien KM (2021-09-03). "GM1 Gangliosidosis-A Mini-Review". Frontiers in Genetics. 12: 734878. doi:10.3389/fgene.2021.734878. PMC 8446533. PMID 34539759.
  • Bley AE, Giannikopoulos OA, Hayden D, Kubilus K, Tifft CJ, Eichler FS (November 2011). "Natural history of infantile G(M2) gangliosidosis". Pediatrics. 128 (5): e1233–e1241. doi:10.1542/peds.2011-0078. PMC 3208966. PMID 22025593.

ncbi.nlm.nih.gov

  • Caciotti A, Garman SC, Rivera-Colón Y, Procopio E, Catarzi S, Ferri L, et al. (July 2011). "GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812 (7): 782–790. doi:10.1016/j.bbadis.2011.03.018. PMC 3210552. PMID 21497194.
  • Jarnes Utz JR, Kim S, King K, Ziegler R, Schema L, Redtree ES, Whitley CB (June 2017). "Infantile gangliosidoses: Mapping a timeline of clinical changes". Molecular Genetics and Metabolism. 121 (2): 170–179. doi:10.1016/j.ymgme.2017.04.011. PMC 5727905. PMID 28476546.
  • Rha AK, Maguire AS, Martin DR (2021-04-09). "GM1 Gangliosidosis: Mechanisms and Management". The Application of Clinical Genetics. 14: 209–233. doi:10.2147/TACG.S206076. PMC 8044076. PMID 33859490.
  • Nicoli ER, Annunziata I, d'Azzo A, Platt FM, Tifft CJ, Stepien KM (2021-09-03). "GM1 Gangliosidosis-A Mini-Review". Frontiers in Genetics. 12: 734878. doi:10.3389/fgene.2021.734878. PMC 8446533. PMID 34539759.
  • Bley AE, Giannikopoulos OA, Hayden D, Kubilus K, Tifft CJ, Eichler FS (November 2011). "Natural history of infantile G(M2) gangliosidosis". Pediatrics. 128 (5): e1233–e1241. doi:10.1542/peds.2011-0078. PMC 3208966. PMID 22025593.

semanticscholar.org

api.semanticscholar.org

  • Regier DS, Kwon HJ, Johnston J, Golas G, Yang S, Wiggs E, et al. (March 2016). "MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis". American Journal of Medical Genetics. Part A. 170 (3): 634–644. doi:10.1002/ajmg.a.37468. PMID 26646981. S2CID 19466710.